These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

545 related items for PubMed ID: 17926641

  • 1. The short hairpin RNA driven by polymerase II suppresses both wild-type and lamivudine-resistant hepatitis B virus strains.
    Ren GL, Fang Y, Ma HH, Lei YF, Wang D, Xu MC, Wang PZ, Huang CX, Nie OH, Sun YT, Bai XF.
    Antivir Ther; 2007; 12(6):865-76. PubMed ID: 17926641
    [Abstract] [Full Text] [Related]

  • 2. Hepatitis B virus is inhibited by RNA interference in cell culture and in mice.
    Ying RS, Zhu C, Fan XG, Li N, Tian XF, Liu HB, Zhang BX.
    Antiviral Res; 2007 Jan; 73(1):24-30. PubMed ID: 16844238
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Long-term inhibition of hepatitis B virus in transgenic mice by double-stranded adeno-associated virus 8-delivered short hairpin RNA.
    Chen CC, Ko TM, Ma HI, Wu HL, Xiao X, Li J, Chang CM, Wu PY, Chen CH, Han JM, Yu CP, Jeng KS, Hu CP, Tao MH.
    Gene Ther; 2007 Jan; 14(1):11-9. PubMed ID: 16929350
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Specific anti-viral effects of RNA interference on replication and expression of hepatitis B virus in mice.
    Wu Y, Huang AL, Tang N, Zhang BQ, Lu NF.
    Chin Med J (Engl); 2005 Aug 20; 118(16):1351-6. PubMed ID: 16157029
    [Abstract] [Full Text] [Related]

  • 7. Supportive role played by precore and preS2 genomic changes in the establishment of lamivudine-resistant hepatitis B virus.
    Ohkawa K, Takehara T, Kato M, Deguchi M, Kagita M, Hikita H, Sasakawa A, Kohga K, Uemura A, Sakamori R, Yamaguchi S, Miyagi T, Ishida H, Tatsumi T, Hayashi N.
    J Infect Dis; 2008 Oct 15; 198(8):1150-8. PubMed ID: 18713056
    [Abstract] [Full Text] [Related]

  • 8. Differential inhibition of lamivudine-resistant hepatitis B virus by allele-specific RNAi.
    Teng X, Xu WZ, Hao ML, Fang Y, Zhao YX, Chen SJ, Li D, Gu HX.
    J Virol Methods; 2010 Sep 15; 168(1-2):6-12. PubMed ID: 20403386
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of multiple gene expression and virus replication of HBV by stable RNA interference in 2.2.15 cells.
    Ren X, Luo G, Xie Z, Zhou L, Kong X, Xu A.
    J Hepatol; 2006 Apr 15; 44(4):663-70. PubMed ID: 16466826
    [Abstract] [Full Text] [Related]

  • 10. Effective inhibition of HBV replication in vivo by anti-HBx short hairpin RNAs.
    Carmona S, Ely A, Crowther C, Moolla N, Salazar FH, Marion PL, Ferry N, Weinberg MS, Arbuthnot P.
    Mol Ther; 2006 Feb 15; 13(2):411-21. PubMed ID: 16337206
    [Abstract] [Full Text] [Related]

  • 11. Stable inhibition of hepatitis B virus expression and replication in HepG2.2.15 cells by RNA interference based on retrovirus delivery.
    Jia F, Zhang YZ, Liu CM.
    J Biotechnol; 2007 Jan 30; 128(1):32-40. PubMed ID: 17049658
    [Abstract] [Full Text] [Related]

  • 12. Stable inhibition of hepatitis B virus proteins by small interfering RNA expressed from viral vectors.
    Moore MD, McGarvey MJ, Russell RA, Cullen BR, McClure MO.
    J Gene Med; 2005 Jul 30; 7(7):918-25. PubMed ID: 15756649
    [Abstract] [Full Text] [Related]

  • 13. B7-DC-silenced dendritic cells induce stronger anti-HBV immunity in transgenic mice.
    Fan Y, Jiang WZ, Wen JJ, Hao WL, Du JN, Liu X, Qian M.
    Arch Virol; 2009 Jul 30; 154(11):1813-21. PubMed ID: 19838621
    [Abstract] [Full Text] [Related]

  • 14. Antisense oligonucleotides targeted against asialoglycoprotein receptor 1 block human hepatitis B virus replication.
    Yang J, Bo XC, Ding XR, Dai JM, Zhang ML, Wang XH, Wang SQ.
    J Viral Hepat; 2006 Mar 30; 13(3):158-65. PubMed ID: 16475991
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of hepatitis B virus replication by shRNAs in stably HBV expressed HEPG2 2.2.15 cell lines.
    Kayhan H, Karatayli E, Turkyilmaz AR, Sahin F, Yurdaydin C, Bozdayi AM.
    Arch Virol; 2007 Mar 30; 152(5):871-9. PubMed ID: 17245534
    [Abstract] [Full Text] [Related]

  • 16. Effect of various pyrimidines possessing the 1-[(2-hydroxy-1-(hydroxymethyl)ethoxy)methyl] moiety, able to mimic natural 2'-deoxyribose, on wild-type and mutant hepatitis B virus replication.
    Kumar R, Semaine W, Johar M, Tyrrell DL, Agrawal B.
    J Med Chem; 2006 Jun 15; 49(12):3693-700. PubMed ID: 16759112
    [Abstract] [Full Text] [Related]

  • 17. Whole genome expression profiling of hepatitis B virus-transfected cell line reveals the potential targets of anti-HBV drugs.
    Ding XR, Yang J, Sun DC, Lou SK, Wang SQ.
    Pharmacogenomics J; 2008 Feb 15; 8(1):61-70. PubMed ID: 17505500
    [Abstract] [Full Text] [Related]

  • 18. Differences of YMDD mutational patterns, precore/core promoter mutations, serum HBV DNA levels in lamivudine-resistant hepatitis B genotypes B and C.
    Pan XP, Li LJ, Du WB, Li MW, Cao HC, Sheng JF.
    J Viral Hepat; 2007 Nov 15; 14(11):767-74. PubMed ID: 17927612
    [Abstract] [Full Text] [Related]

  • 19. The oncogenic potential of hepatitis B virus rtA181T/ surface truncation mutant.
    Lai MW, Yeh CT.
    Antivir Ther; 2008 Nov 15; 13(7):875-9. PubMed ID: 19043921
    [Abstract] [Full Text] [Related]

  • 20. Efficient inhibition of hepatitis B virus replication by small interfering RNAs targeted to the viral X gene in mice.
    Shin D, Kim SI, Kim M, Park M.
    Virus Res; 2006 Aug 15; 119(2):146-53. PubMed ID: 16443303
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.